PMID: 42128321

Semaglutide, at a dose that produces modest weight loss, induces mild suppression of bone remodeling in healthy control rats and those with chronic kidney disease.

Allen Matthew R, Metzger Corinne E, Chen Neal X, Tinsley Ian C, DiMarchi Richard D, O'Neill Kalisha, Matter Emily K, Moe Sharon M

Bone · 2026

Vol. 210, pp. 117933

View on PubMedDOI

This entry links to third-party literature. For research use only.

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.